LifeMine Therapeutics, a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, has completed a USD175 million Series C financing. The financing was led by new investor Fidelity Management & Research Company, with participation by additional new investors Invus and 3W Partners Capital; GlaxoSmithKline (GSK)

Climate X, a London-based climate risk analytics provider, has raised GBP4.1 million in seed funding. CommerzVentures and A/O PropTech led the round – joined by Voyagers Climate Tech Fund, Blue Impact Ventures, Deloitte LLP and angel investors including David Rowan (founding Editor-in-Chief at WIRED), Kat Borlongan (former Director at La

European lingerie brand Hunkemöller is to be acquired by Parcom, a Dutch investment company, and Opportunity Partners, the investment company of Dutch entrepreneur Robert van der Wallen. Global investment firm Carlyle, an existing shareholder, will reinvest for a minority stake.  The new investors have an established track record in developing

Skyports, an electric air taxi infrastructure and drone services provider, has raised USD23 million in the first close of its Series B funding round. The capital, from a combination of new and existing investors, will enable Skyports to consolidate its position as a global leader in the advanced air mobility